Literature DB >> 11672930

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

M T Shata1, M S Reitz, A L DeVico, G K Lewis, D M Hone.   

Abstract

CD8(+) T-cell responses provide beneficial antiviral immunity against human immunodeficiency virus 1 (HIV-1). In this study, we show that intragastric vaccination with a Salmonella HIV-1 Env DNA vaccine vector generates Env-specific CD8(+) T-cells, both in mucosal and systemic lymphoid tissue. By contrast, intramuscular vaccination with the Env DNA vaccine alone only induced systemic CD8(+) T-cells. To our knowledge, this is the first report showing both mucosal and systemic CD8(+) T-cell responses following vaccination with a Salmonella vaccine vector. These data suggest that this mode of HIV-1 DNA vaccine delivery will be advantageous over parenterally administered HIV-1 DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672930     DOI: 10.1016/s0264-410x(01)00330-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice.

Authors:  Jong-Soo Lee; Haryoung Poo; Dong P Han; Seung-Pyo Hong; Kwang Kim; Michael W Cho; Eun Kim; Moon-Hee Sung; Chul-Joong Kim
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.

Authors:  Beatriz del Rio; Jesus Lajara Fuente; Vera Neves; Raymond Dattwyler; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  Vaccine       Date:  2010-08-08       Impact factor: 3.641

Review 3.  HIV vaccines: progress to date.

Authors:  C Mee Ling Munier; Christopher R Andersen; Anthony D Kelleher
Journal:  Drugs       Date:  2011-03-05       Impact factor: 9.546

4.  Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors:  V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 5.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

7.  Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen.

Authors:  Beatriz del Rio; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

8.  Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.

Authors:  Beatriz del Rio; Raymond J Dattwyler; Miguel Aroso; Vera Neves; Luciana Meirelles; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2008-07-16

Review 9.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

Review 10.  Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Authors:  Jordan Poles; Yelina Alvarez; Catarina E Hioe
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.